Target intelligence / Profile preview

Vitamin B6 transporter

Molecular classification
Transporter
01

Overview

The Vitamin B6 transporter facilitates the uptake and intracellular distribution of vitamin B6 vitamers, including non-phosphorylated forms like pyridoxine (PN), pyridoxal (PL), and pyridoxamine (PM), as well as the active phosphorylated form pyridoxal 5'-phosphate (PLP), across plasma membranes and into subcellular compartments such as mitochondria. In mammals, tissues transport these non-phosphorylated vitamers from plasma after dephosphorylation of circulating PLP by alkaline phosphatases, enabling conversion to PLP inside cells for use as a coenzyme in over 100 enzymes involved in amino acid metabolism, heme biosynthesis, and glycogen breakdown. Specific carriers like the mitochondrial transporter Mtm1p in yeast (homologous roles likely in humans) import PLP into mitochondria, linking B6 transport to iron homeostasis and Fe-S cluster assembly. In plants and yeast, plasma membrane transporters from the purine permease (PUP) family or Tpn1p/Bsu1 handle extracellular import of non-phosphorylated B6, while dynamic membrane pores formed by NAPE-PLD may aid diffusion of charged PLP across organelle membranes in the presence of bile acids. Dysregulation of B6 transport contributes to altered vitamer levels in diseases like cancer, where Wnt signaling modulates related enzymes like PDXK, potentially shifting B6 to inactive forms and affecting tumor growth. No drugs directly target these transporters, but their role is critical for preventing B6 deficiency-related metabolic disruptions.

Other names
Vitamin B6 membrane transporterB6 vitamer transporterPLP transporter (for phosphorylated forms)PN/PL/PM transporter (for non-phosphorylated forms)
02

Biological functions

Cellular uptake and distribution of vitamin B6 vitamers (PN, PL, PM, PLP)subcellular transport into mitochondria and organellesmaintenance of vitamin B6 cofactor levels for enzymatic reactions
03

Disease associations

Other (potential links to metabolic disorders via B6 deficiency, cancer via dysregulated B6 metabolism in Wnt signaling)
04

Safety considerations

Potential disruption of mitochondrial iron homeostasis and heme biosynthesis if impaired (observed in yeast homolog Mtm1p deletion)

Beyond the preview

Go deeper on Vitamin B6 transporter.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vitamin B6 transporter.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call